Drug intelligence / Profile preview

Waycart-6

Development stage
Unknown
Lead developer
SBM Enterprises
Modality
Small Molecules
Administration
Oral
01

Overview

Waycart-6 is a branded generic formulation of deflazacort, a synthetic glucocorticoid corticosteroid. Developed and marketed by SBM Enterprises (also known as SBM Pharmaceuticals) in India, it contains 6 mg of deflazacort as the active ingredient. Deflazacort is a prodrug that is metabolized to its active form, 21-desacetyl-deflazacort, which binds to glucocorticoid receptors to exert potent anti-inflammatory and immunosuppressive effects. It is primarily indicated for the treatment of Duchenne muscular dystrophy (DMD), where it helps to maintain muscle strength and slow disease progression by reducing muscle inflammation. Additionally, Waycart-6 is used to manage a wide range of inflammatory and autoimmune conditions, including asthma, rheumatoid arthritis, severe allergic reactions, and various skin diseases.

Brand names
Waycart-6Waycart6Waycart 6
Other names
deflazacort 6 mgdeflazacort6 mgdeflazacort-6 mg
02

Targets

GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on Waycart-6.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Waycart-6.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call